IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 241 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,188 | -35.4% | 1,360,000 | 0.0% | 0.08% | -31.5% |
| Q2 2023 | $9,574 | +15.2% | 1,360,000 | 0.0% | 0.12% | +8.8% |
| Q1 2023 | $8,310 | -4.4% | 1,360,000 | 0.0% | 0.11% | -0.9% |
| Q4 2022 | $8,690 | -99.9% | 1,360,000 | +17.2% | 0.12% | -24.8% |
| Q3 2022 | $11,113,000 | -13.2% | 1,160,000 | 0.0% | 0.15% | -5.0% |
| Q2 2022 | $12,806,000 | +494.0% | 1,160,000 | +411.7% | 0.16% | +496.3% |
| Q1 2019 | $2,156,000 | +7.5% | 226,681 | 0.0% | 0.03% | -6.9% |
| Q4 2018 | $2,006,000 | -55.5% | 226,681 | -43.4% | 0.03% | -50.0% |
| Q3 2018 | $4,507,000 | -8.7% | 400,603 | +3.9% | 0.06% | -14.7% |
| Q2 2018 | $4,934,000 | – | 385,446 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |